ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon inaugurates first manufacturing facility in US
Biocon Ltd has inaugurated its first US manufacturing facility in Cranbury, New Jersey, operated by its subsidiary, Biocon Generics Inc. Following the acquisition of the Oral Solid Dosage facility from Eywa Pharma Inc in 2023, Biocon invested over USD 30 m
Announcement as on 11 September 2025

Biocon shares rise 2% after USFDA concludes inspection with 5 observations
Biocon shares: The inspection, carried out from August 26 to September 3, 2025, spanned multiple operational areas such as drug substance manufacturing, analytical quality control labs, microbiology facilities, and warehouses.
Announcement as on 05 September 2025

Biocon reports 95% YoY decline in net profit, operating revenue up 15%
Biocon's Q1 net profit declined 95% year-on-year, but on a like-for-like basis, profit after tax increased by 65%. Revenue grew 15% to Rs 3,942 crore, fueled by Biocon Biologics' 18% growth and Syngene's 11% increase. A recent QIP of Rs 4,500 crores will s
Announcement as on 07 August 2025

Biocon Biologics launches product for autoimmune diseases in Australia
Biocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating autoimmune diseases like rheumatoid arthritis. Marketed through Generic Health, Nepexto aims to broaden patient access in the coun
Announcement as on 23 July 2025

Biocon Biologics gets USFDA nod for diabetes medication
Biocon Biologics has secured USFDA approval for Kirsty. Kirsty is an interchangeable biosimilar to NovoLog, used for diabetes treatment. It is a rapid-acting insulin analog. The medication will be available in prefilled pens and vials. This approval expand
Announcement as on 16 July 2025

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 391.34
  • 12Day Average: 389.98
  • 20Day Average: 387.02
  • 50Day Average: 379.42
  • 100Day Average: 384.41
  • 150Day Average: 375.11
  • 200Day Average: 372.39

532523 Indicators & signals

Indicator MACD (12,26,9)

388.63, 385.26, 3.51
Indicator MACD is in positive zone

Indicator ADX (14)

0.63, 23.36, 23.07
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
13 Fri Mar 2026 383.20 382.35 to 398.65 -2.42% 1.52 times
12 Thu Mar 2026 392.70 388.80 to 397.30 -0.67% 0.2 times
11 Wed Mar 2026 395.35 394.45 to 402.75 -0.08% 0.37 times
10 Tue Mar 2026 395.65 393.20 to 398.45 1.5% 0.5 times
09 Mon Mar 2026 389.80 379.35 to 390.90 -0.17% 0.17 times
06 Fri Mar 2026 390.45 386.60 to 394.20 1% 0.21 times
05 Thu Mar 2026 386.60 379.15 to 389.00 2.21% 0.44 times
04 Wed Mar 2026 378.25 375.70 to 385.30 -2.6% 6.25 times
02 Mon Mar 2026 388.35 371.00 to 390.20 -0.36% 1.38 times
27 Fri Feb 2026 389.75 389.00 to 396.85 -1.09% 0.1 times
26 Thu Feb 2026 394.05 389.15 to 400.90 -0.4% 0.37 times
25 Wed Feb 2026 395.65 390.30 to 396.85 1.36% 1.18 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top